tender for procurement of specialty drugs for the year 2026-27 , acyclovir intravenous infusion ip 500 mg , acyclovir tab ip 800 mg , adenosine inj ip 3 mg/ml , alteplase inj 50 mg , amphotericin b inj ip 50 mg/ml , amphotericin b liposomal inj 50 mg , ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g , aripiprazole tab ip 10 mg , artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)] , artesunate inj ip 60 mg , atomoxetine tab 10 mg , atomoxetine tab 25 mg , aztreonam inj usp 1 gm , barium sulphate suspension bp/usp 95% w/v , bethanechol chloride tab bp 25 mg , botulinum toxin a inj (freeze-dried powder for injection) 50 units , botulinum toxin a inj (freeze-dried powder for injection) 100 units , caffeine citrate inj bp/usp 20 mg/ml , calcitriol tab 0.25 mcg , calcium acetate tab 667 mg , carbimazole tab ip 5 mg , cefpodoxime oral suspension ip 100 mg/5 ml , ceftazidime and avibactam inj each vial contains ceftazidime pentahydrate equivalent to ceftazidime 2 g and avibactam sodium equivalent to avibactam 0.5 g , ceftazidime for inj ip 1 gm , cefuroxime axetil tab ip 500 mg , citicoline inj ip 500 mg , clarithromycin tab ip 500 mg , clindamycin cap ip 300 mg , clindamycin gel 1% , clobetasol propionate + salicylic acid ointment 0.05% w/w + 3.00% w/w , clopidogrel+aspirin tab ip 75 mg + 75 mg , colistimethate inj ip 3 miu , cyclosporine cap ip 100 mg , dabigatran cap 110 mg , dapagliflozin tab 10 mg , dapsone tab ip 100 mg , darifenacin tab 7.5 mg , desonide lotion 0.05% , dicumarol tab 25 mg , digoxin paediatric solution ip 50 mcg/ml , disodium hydrogen citrate syrup 1.53 gm/5 ml , divalproex sodium prolonged release tab ip 500 mg , doxycycline inj 100 mg , d-penicillamine cap usp 250 mg ,